NCT05434832

Brief Summary

A randomized controlled trial is conducted to evaluation of the effects of virtual reality and local cold-vibration applications in reducing anxiety, fear and pain due to intramuscular (IM) injection in children aged 5-10 years. It has been determined that the use of Virtual Reality and local cold-vibration are effective interventions in reducing anxiety, fear and pain due to IM injection in children aged 5-10 years.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
117

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2019

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 27, 2021

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2022

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 27, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
Last Updated

June 28, 2022

Status Verified

June 1, 2022

Enrollment Period

2.6 years

First QC Date

June 16, 2022

Last Update Submit

June 22, 2022

Conditions

Keywords

childpainanxietyfearintramuscular injectionlocal cold-vibrationvirtual realitypediatric nurse

Outcome Measures

Primary Outcomes (6)

  • Anxiety assesed by Children's State Anxiety

    The Children's State Anxiety (CAS-S). The CAS-S assesses children's anxiety and uses before medical procedures. This scale is drawn like a thermometer with a bulb at the bottom and also includes horizontal lines at intervals going up to the top (0-10). This scale ranges from 0 to 10. Higher values represent higher anxiety

    Before the intramuscular injection

  • Anxiety assesed by Children's State Anxiety

    The Children's State Anxiety (CAS-S). The CAS-S assesses children's anxiety and uses before medical procedures. This scale is drawn like a thermometer with a bulb at the bottom and also includes horizontal lines at intervals going up to the top (0-10). This scale ranges from 0 to 10. Higher values represent higher anxiety

    Within the first 5 minutes after the intramuscular injection

  • Fear assesed by Child Fear Scale

    The Child Fear Scale (CFS). The Child Fear Scale will use.This one-item scale measures procedure-related fear in children, consists of five sex-neutral faces, ranges from 0 (no fear) to extreme fear. This rating scale ranges from 0 to 4. It ranges from a no fear (neutral) face (0) on the far left to a face showing extreme fear on the far right. Higher scores mean a worse outcome. The rater responds indicates the level of fear.

    Before the intramuscular injection

  • Fear assesed by Child Fear Scale

    The Child Fear Scale (CFS). The Child Fear Scale will use.This one-item scale measures procedure-related fear in children, consists of five sex-neutral faces, ranges from 0 (no fear) to extreme fear. This rating scale ranges from 0 to 4. It ranges from a no fear (neutral) face (0) on the far left to a face showing extreme fear on the far right. Higher scores mean a worse outcome. The rater responds indicates the level of fear.

    Within the first 5 minutes after the intramuscular injection

  • Pain assesed by Wong-Baker FACES

    Wong-Baker FACES (WB-FACES) Pain Rating Scale used. This scale uses in children aged 3 and older to rate pain severity. This numeric rating scale ranges from 0 to 10. Faces show emotions from smiling (0 = very happy/ no pain) to crying (10 = hurts worst).

    Before the intramuscular injection

  • Pain assesed by Wong-Baker FACES

    Wong-Baker FACES (WB-FACES) Pain Rating Scale used. This scale uses in children aged 3 and older to rate pain severity. This numeric rating scale ranges from 0 to 10. Faces show emotions from smiling (0 = very happy/ no pain) to crying (10 = hurts worst).

    Within the first 5 minutes after the intramuscular injection

Study Arms (3)

Virtual Reality Group

EXPERIMENTAL

watching the cartoon by wearing virtual reality glass to the child during the intramuscular injection

Behavioral: Virtual Reality

Local cold-vibration Group

EXPERIMENTAL

The local cold-vibration device is placed 5 cm above the area to be injected

Behavioral: Local cold-vibration

Control Group

NO INTERVENTION

standart care

Interventions

Virtual RealityBEHAVIORAL

Distraction method

Virtual Reality Group

Distraction method

Local cold-vibration Group

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The child is between the ages of 5 and 10
  • Having intramuscular (IM) injection therapy
  • Absence of Audio-Visual-Sensation loss problem
  • No communication problem
  • Absence of mental retardation
  • Absence of a disease causing chronic pain
  • No history of fainting during injection
  • Not taking any analgesic medication in the last 4 hours

You may not qualify if:

  • Failure of IM application at one time
  • The child in the virtual reality application group removes the virtual reality glasses during the IM injection.
  • The child in the group receiving Buzzy application removes the Buzzy device during IM injection.
  • Not wanting to fill the scales after the application
  • Diagnosis or suspicion of COVID-19 (having any of the symptoms such as fever, cough, respiratory distress, chest pain, loss of taste and smell, sore throat, contact with a COVID-19 positive person)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ayşegül İşler Dalgiç

Antalya, Akdeniz University, 07058, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, ProceduralPainAnxiety Disorders

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Officials

  • AYŞEGÜL İŞLER DALGIÇ, Professor

    Akdeniz University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A total of three groups as 2 intervention (virtual reality, local cold-vibration) and control group (routine application)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

June 16, 2022

First Posted

June 28, 2022

Study Start

June 1, 2019

Primary Completion

December 27, 2021

Study Completion

June 27, 2022

Last Updated

June 28, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations